Impact of Genomic Deletion RD16 on the Expression of the Mycobacterium bovis BCG Moreau VapBC47 Toxin-Antitoxin System

• Published in: Current issues in molecular biology Vol. 45; no. 8; pp. 6538 - 6549
• Main Authors: Pagani, Talita Duarte, Corrêa, Paloma Rezende, Lima, Cristiane, Gomes, Leonardo Henrique Ferreira, Schwarz, Marcos Gustavo Araujo, Galvão, Teca Calcagno, Degrave, Wim Maurits, Valadares, Napoleão Fonseca, Mendonça-Lima, Leila
• Format: Journal Article
• Language: English
• Published: MDPI 07.08.2023; MDPI AG
• Subjects: BCG vaccine; Mycobacterium bovis BCG Moreau; Mycobacterium tuberculosis; toxin–antitoxin system; VapBC47
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb45080412

Mycobacterium bovis BCG is the only vaccine against tuberculosis. The variable forms of cultivation throughout the years, before seed-lots were developed, allowed in vitro evolution of the original strain, generating a family of vaccines with different phenotypic and genotypic characteristics. Molecular studies revealed regions of difference (RDs) in the genomes of the various BCG strains. This work aims to characterize the gene pair rv3407-rv3408 (vapB47-vapC47), coding for a toxin–antitoxin system of the VapBC family, and to evaluate possible transcriptional effects due to the adjacent BCG Moreau-specific genomic deletion RD16. We show that these genes are co-transcribed in BCG strains Moreau and Pasteur, and that the inactivation of an upstream transcriptional repressor (Rv3405c) due to RD16 has a polar effect, leading to increased vapBC47 expression. Furthermore, we detect VapB47 DNA binding in vitro, dependent on a 5′ vapB47 sequence that contributes to a palindrome, spanning the promoter and coding region. Our data shed light on the regulation of VapBC systems and on the impact of the BCG Moreau RD16 deletion in the expression of adjacent genes, contributing to a better understanding of BCG Moreau physiology.